Already have an account? Sign-in to get started.

Incorporating New Advances and the Latest Science to Improve Recognition and Treatment of Idiopathic Pulmonary Fibrosis


To view this online CME activity and complete the posttest and evaluation, please CLICK "VIEW ACTIVITY" BUTTON UNDER STEP 1.

Or CLICK  the following link:

Overview:  In this activity, an expert in leading IPF expert will analyze and interpret recent clinical findings that speak to the rapidly changing management landscape in IPF, and attempt to place current evidence in the context of daily medical practice.

Target Audience:  This activity will directly target pulmonologists and nurses who are presently active in patient care. Additionally, other professionals interested in IPF will be able to access and review the activity through a digital network.


Upon completion of this activity, participants should be better able to:

  • Describe the signs and symptoms of idiopathic pulmonary fibrosis (IPF).
  • Differentiate IPF from interstitial lung disorders according to evidence-based guidelines.
  • Select IPF therapy according to current guidelines, relevant clinical data, and patient preferences.
  • Implement evidence-based strategies for monitoring IPF treatment response, managing adverse events, and improving patient quality of life.


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and PeerView Institute For Medical Education. The University of Cincinnati is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Cincinnati designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Your Status



People have also taken...